Myocardial Infarction Current Events | Myocardial Infarction News | 10
|
| Page
10 of
16 |
311 Results |
|
|
|
Sort By:
Page Views | Date |
Reanalysis of controversial meta-analysis says writing off rosiglitazone may be premature
Rosiglitazone, a drug marketed by GlaxoSmithKline as Avandia® for the treatment of type 2 diabetes, came under fire after an article published online May 21 by the New England Journal of Medicine linked it to significantly increased risk of heart attack and cardiovascular death. view more (2007-08-10)
Research finds link between depression
Depression nearly triples the risk of death following a heart attack, even when accounting for other heart attack risk factors, according to research presented today at the American College of Neuropsychopharmacology (ACNP) annual meeting, which showed that among 360 depressed, post myocardial infarction patients followed for more than six years,... view more... (2007-12-10)
SIMPLE RISK INDEX FOR ASSESSING HEART-ATTACK OUTCOME (pp 1566, 1571)
Paramedical and clinical staff could use a straightforward risk-assessment model to estimate the likely outcome of heart-attack patients outside the hospital environment and immediately after admission to emergency departments, conclude authors of a study in this week's issue of THE LANCET. view more (2001-11-07)
Statins benefit for kidney-transplant patients
Embargo: 0001 H (London time) Tuesday 3 June 2003. Authors of a study published on THE LANCET'S website today (www.thelancet.com) highlight how statins (cholesterol-lowering drugs) could offer protection against cardiovascular disease for people who have undergone kidney transplantation. Kidney-transplant patients are at an increased risk of... view more... (2003-05-30)
HEART FAILURE UNDERDIAGNOSED IN UK PRIMARY CARE (pp 432, 439)
A UK study published in this week’s issue of THE LANCET suggests that heart failure is more common than previously thought. New strategies involving the assessment of left-ventricular function in patients with suspected heart failure could lead to more successful treatment. An estimated 120,000 patients are admitted to hospital every year... view more... (2001-08-08)
Will screening for aortic aneurysm be effective?
Pilot screening programmes for abdominal aortic aneurysms in men aged 65 are due to be launched in England this year, but is this move too hasty? Two experts debate the issue in this week's BMJ. view more (2008-04-18)
Creatinine Increase in Elderly Means Increased Renal Disease, Mortality
Even small increases in serum creatinine levels during hospitalization raise the risk of end stage renal disease and mortality of elderly patients over the long term, according to a University of Alabama at Birmingham (UAB) study in the March issue of the Archives of Internal Medicine. view more (2008-04-16)
ESC Congress 2004: Diabetes and the heart
The Euro Heart Survey on the diabetic state of patients with coronary artery disease view more (2004-08-30)
Comparison of anticoagulants for angioplasty show similar outcomes
In a comparison of anticoagulants and stents for use with angioplasty following a heart attack, the anticoagulants abciximab and tirofiban had similar outcomes for some cardiac measures within 90 minutes after the procedure, while patients who received stents that released the drug sirolimus had a lower risk of major adverse cardiac events within... view more... (2008-03-31)
Secrets of success in the rapid treatment of heart attacks
Some of the key elements for success in the rapid treatment of heart attacks have been identified by researchers at Yale School of Medicine in a recent issue of Circulation: Journal of the American Heart Association. view more (2006-03-01)
Drug-eluting stents prove more effective, equally as safe as bare-metal stents
The Cardiovascular Research Foundation (CRF) announced that its landmark study comparing the safety and efficacy of drug-eluting stents and bare-metal stents was published today in The New England Journal of Medicine. view more (2009-05-07)
ESC Congress 2003: Different outcomes in patients suffering from heart attacks among countries with different Gross National Income
IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Recent publications suggested different outcomes in patients admitted to hospitals with... view more... (2003-09-01)
Potential heart benefit found in stem cells
Stem cell transplantation is among one of the most exciting and hotly debated areas of medical research today. view more (2006-03-14)
Penn researchers find psoriasis patients at increased risk for heart attack
Psoriasis is an independent risk factor for myocardial infarction (MI; heart attack), and this risk is greatest in young patients with severe psoriasis. view more (2006-10-11)
SPIRIT IV trial shows everolimus stent sets new standard for event-free survival
Late-breaking data from SPIRIT IV, a large-scale multi-center study of nearly 4,000 patients in the U.S., shows that an everolimus-eluting stent demonstrated enhanced safety and efficacy in the treatment of de novo native coronary artery lesions when compared to a paclitaxel-eluting stent, and showed that "low late loss" may be achieved... view more... (2009-09-24)
Drug-eluting stents more effective, equally as safe as bare metal stents in clinical trial
Late-breaking data from the HORIZONS AMI (Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction) trial reveal that after one year, use of a drug-eluting (paclitaxel) stent demonstrated significantly reduced rates of target lesion revascularization (TLR) and binary angiographic restenosis when compared to the use of... view more... (2008-10-16)
Gene variants linked with increased risk of death among heart patients treated with beta-blockers
Patients with certain gene variants who were prescribed beta-blocker drugs after acute coronary syndrome (ACS) had an increased risk of death over the next three years, according to a study in the September 28 issue of JAMA. view more (2005-09-28)
Lower mortality rates associated with hospitals that rank highest on quality of care indicators
A new study from the Harvard School of Public Health (HSPH) shows that patients who go to hospitals ranked higher according to specific quality measures have a lower chance of dying than patients treated at lower-ranked hospitals. view more (2007-07-16)
Hospitals that participate in clinical trials may provide better patient care
Hospitals that participate in clinical trials appear to provide better care for patients with heart attacks or other acute heart events and have lower death rates than hospitals that do not participate in clinical trials, according to a report in the March 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. view more (2008-03-25)
Part of drug trial for patients with atrial fibrillation discontinued
Study treatments for the ACTIVE W trial of the ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) program have been discontinued due to a significant difference in efficacy, in favour of the standard oral anticoagulation (OAC) over antiplatelet therapy (clopidogrel plus aspirin). view more (2005-09-07)
|
|
| Page
10 of
16 |
311 Results |
|
|
|
Sort By:
Page Views | Date |
|
